ArticleCancer immunology research2022

NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy.

Ti Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.